MedPath

Upjohn EESV

🇳🇱Netherlands
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

89

CIMA_AEMPS:67
NMPA:14
EMA:4
+1 more agencies

Drug Approvals

Pregabalin Capsules

Product Name
乐瑞卡
Approval Number
国药准字HJ20150620
Approval Date
Nov 26, 2024
NMPA

Pregabalin Capsules

Product Name
乐瑞卡
Approval Number
国药准字HJ20150623
Approval Date
Nov 26, 2024
NMPA

Pregabalin Capsules

Product Name
乐瑞卡
Approval Number
国药准字HJ20150619
Approval Date
Nov 26, 2024
NMPA

Pregabalin Capsules

Product Name
乐瑞卡
Approval Number
国药准字HJ20150622
Approval Date
Nov 26, 2024
NMPA

Sildenafil Citrate Tablets

Product Name
枸橼酸西地那非片
Approval Number
国药准字HJ20200002
Approval Date
Sep 29, 2024
NMPA

Sildenafil Citrate Orodispersible Tablets

Product Name
枸橼酸西地那非口崩片
Approval Number
国药准字HJ20190071
Approval Date
Jun 27, 2024
NMPA

Pregabalin Capsules

Product Name
乐瑞卡
Approval Number
国药准字J20160021
Approval Date
Jul 7, 2020
NMPA

Pregabalin Capsules

Product Name
乐瑞卡
Approval Number
国药准字J20160022
Approval Date
Jul 7, 2020
NMPA

Pregabalin Capsules

Product Name
乐瑞卡
Approval Number
H20150623
Approval Date
Apr 29, 2020
NMPA

Pregabalin Capsules

Product Name
乐瑞卡
Approval Number
H20150620
Approval Date
Apr 29, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.